Beijing Luzhu Biotechnology Co., Ltd.
2 clinical trials · Sponsor
◉ Watch Beijing Luzhu Biotechnology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine (NCT06088745) | Beijing Luzhu Biotechnology Co., Ltd. | 2023-09-28 |
| A Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine (NCT05750017) | Beijing Luzhu Biotechnology Co., Ltd. | 2023-03-23 |
Track Beijing Luzhu Biotechnology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.